Symptom | Therapy | Effects |
---|---|---|
Migraine | As prophylaxis, reduces the frequency of migraine attacks | |
Sodium valproate [155] | Anecdotal cases | |
Cognitive decline | Acetylcholinesterase inhibitor [121] | Not efficacious on the primary end-point (Vascular Dementia Assessment scale after 18 weeks), but some improvement in relation to frontal-subcortical dysfunction |
Primary and secondary stroke prevention | Unproven and debated benefits |